<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32845119</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8937</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>ACS chemical biology</Title><ISOAbbreviation>ACS Chem Biol</ISOAbbreviation></Journal><ArticleTitle>Pentavalent Sialic Acid Conjugates Block Coxsackievirus A24 Variant and Human Adenovirus Type 37-Viruses That Cause Highly Contagious Eye Infections.</ArticleTitle><Pagination><StartPage>2683</StartPage><EndPage>2691</EndPage><MedlinePgn>2683-2691</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschembio.0c00446</ELocationID><Abstract><AbstractText>Coxsackievirus A24 variant (CVA24v) and human adenovirus 37 (HAdV-37) are leading causative agents of the severe and highly contagious ocular infections acute hemorrhagic conjunctivitis and epidemic keratoconjunctivitis, respectively. Currently, neither vaccines nor antiviral agents are available for treating these diseases, which affect millions of individuals worldwide. CVA24v and HAdV-37 utilize sialic acid as attachment receptors facilitating entry into host cells. Previously, we and others have shown that derivatives based on sialic acid are effective in preventing HAdV-37 binding and infection of cells. Here, we designed and synthesized novel pentavalent sialic acid conjugates and studied their inhibitory effect against CVA24v and HAdV-37 binding and infection of human corneal epithelial cells. The pentavalent conjugates are the first reported inhibitors of CVA24v infection and proved efficient in blocking HAdV-37 binding. Taken together, the pentavalent conjugates presented here form a basis for the development of general inhibitors of these highly contagious ocular pathogens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>Emil</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Ume&#xe5; University, SE90187 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caraballo</LastName><ForeName>R&#xe9;mi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5912-8429</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Ume&#xe5; University, SE90187 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mistry</LastName><ForeName>Nitesh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Section of Virology, Department of Clinical Microbiology, Ume&#xe5; University, SE90185 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zocher</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Interfaculty Institute of Biochemistry, University of T&#xfc;bingen, 72076 T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Weixing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Ume&#xe5; University, SE90187 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>C David</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Ume&#xe5; University, SE90187 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurdiss</LastName><ForeName>Daniel L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584CL Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandra</LastName><ForeName>Naresh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Section of Virology, Department of Clinical Microbiology, Ume&#xe5; University, SE90185 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fr&#xe4;ngsmyr</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Section of Virology, Department of Clinical Microbiology, Ume&#xe5; University, SE90185 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stehle</LastName><ForeName>Thilo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Interfaculty Institute of Biochemistry, University of T&#xfc;bingen, 72076 T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnberg</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Section of Virology, Department of Clinical Microbiology, Ume&#xe5; University, SE90185 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elofsson</LastName><ForeName>Mikael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3219-4669</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Ume&#xe5; University, SE90187 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ume&#xe5; Centre for Microbial Research, Ume&#xe5; University, SE90187 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Biol</MedlineTA><NlmUniqueID>101282906</NlmUniqueID><ISSNLinking>1554-8929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012794">Sialic Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000260" MajorTopicYN="N">Adenoviruses, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030015" MajorTopicYN="N">Enterovirus C, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012794" MajorTopicYN="N">Sialic Acids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="N">Virus Attachment</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors
declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32845119</ArticleId><ArticleId IdType="pmc">PMC7586296</ArticleId><ArticleId IdType="doi">10.1021/acschembio.0c00446</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Azari A. A.; Barney N. P. (2013) Conjunctivitis: a systematic review of diagnosis and treatment. JAMA 310, 1721&#x2013;1729. 10.1001/jama.2013.280318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.280318</ArticleId><ArticleId IdType="pmc">PMC4049531</ArticleId><ArticleId IdType="pubmed">24150468</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchio E. (2005) New medical treatment for viral conjunctivitis. Nippon Ganka Gakkai Zasshi 109, 962&#x2013;984. discussion 985.</Citation><ArticleIdList><ArticleId IdType="pubmed">16408491</ArticleId></ArticleIdList></Reference><Reference><Citation>Skevaki C. L.; Galani I. E.; Pararas M. V.; Giannopoulou K. P.; Tsakris A. (2011) Treatment of viral conjunctivitis with antiviral drugs. Drugs 71, 331&#x2013;347. 10.2165/11585330-000000000-00000.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11585330-000000000-00000</ArticleId><ArticleId IdType="pubmed">21319870</ArticleId></ArticleIdList></Reference><Reference><Citation>(2013) Adenovirus-associated epidemic keratoconjunctivitis outbreaks--four states, 2008&#x2013;2010. MMWR 62, 637&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4604776</ArticleId><ArticleId IdType="pubmed">23945769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L.; Zhao N.; Huang X.; Jin X.; Geng X.; Chan T.-C.; Liu S. (2017) Molecular epidemiology of acute hemorrhagic conjunctivitis caused by coxsackie A type 24 variant in China, 2004&#x2013;2014. Sci. Rep. 7, 45202.10.1038/srep45202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep45202</ArticleId><ArticleId IdType="pmc">PMC5362916</ArticleId><ArticleId IdType="pubmed">28332617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazali O.; Chua K. B.; Ng K. P.; Hooi P. S.; Pallansch M. A.; Oberste M. S.; Chua K. H.; Mak J. W. (2003) An outbreak of acute haemorrhagic conjunctivitis in Melaka, Malaysia. Singapore Med. J. 44, 511&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">15024454</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez G.; Yawata N.; Aoki K.; Kitaichi N. (2019) Challenges in management of epidemic keratoconjunctivitis with emerging recombinant human adenoviruses. J. Clin. Virol. 112, 1&#x2013;9. 10.1016/j.jcv.2019.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2019.01.004</ArticleId><ArticleId IdType="pubmed">30654207</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinger J. R.; Sanchez M. P.; Curtin L. A.; Durkin M.; Matyas B. (1998) Multiple cases of life-threatening adenovirus pneumonia in a mental health care center. Am. J. Respir. Crit. Care Med. 157, 645&#x2013;649. 10.1164/ajrccm.157.2.9608057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.157.2.9608057</ArticleId><ArticleId IdType="pubmed">9476884</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang G.; Yao W.; Yu W.; Mao L.; Sun H.; Yao W.; Tian J.; Wang L.; Bo Z.; Zhu Z.; Zhang Y.; Zhao Z.; Xu W. (2014) Outbreak of epidemic keratoconjunctivitis caused by human adenovirus type 56, China, 2012. PLoS One 9, e110781&#x2013;e110781. 10.1371/journal.pone.0110781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0110781</ArticleId><ArticleId IdType="pmc">PMC4208770</ArticleId><ArticleId IdType="pubmed">25343525</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurokawa M.; Rai S. K.; Ono K.; Gurung R.; Ruit S. (2006) Viral investigation of acute hemorrhagic conjunctivitis outbreak (2003) in Nepal using molecular methods. Southeast Asian J. Trop. Med. Public Health 37, 904&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">17333732</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright P. W.; Strauss G. H.; Langford M. P. (1992) Acute hemorrhagic conjunctivitis. Am. Fam. Physician 45, 173&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">1309404</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh M.-d.; Park S.; Choi Y.; Kim H.; Lee K.; Park W.; Yoo Y.; Kim E.-C.; Choe K. (2003) Acute hemorrhagic conjunctivitis caused by coxsackievirus A24 variant, South Korea, 2002,. Emerging Infect. Dis. 9, 1010&#x2013;1012. 10.3201/eid0908.030190.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0908.030190</ArticleId><ArticleId IdType="pmc">PMC3020616</ArticleId><ArticleId IdType="pubmed">12967504</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnauchow T. M.; Tolson D. L.; Harrison B. A.; Altman E.; Lublin D. M.; Dimock K. (1996) The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J. Virol. 70, 5143&#x2013;5152. 10.1128/JVI.70.8.5143-5152.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.70.8.5143-5152.1996</ArticleId><ArticleId IdType="pmc">PMC190469</ArticleId><ArticleId IdType="pubmed">8764022</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry N.; Inoue H.; Jamshidi F.; Storm R. J.; Oberste M. S.; Arnberg N. (2011) Coxsackievirus A24 variant uses sialic acid-containing O-linked glycoconjugates as cellular receptors on human ocular cells. J. Virol. 85, 11283&#x2013;11290. 10.1128/JVI.05597-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05597-11</ArticleId><ArticleId IdType="pmc">PMC3194947</ArticleId><ArticleId IdType="pubmed">21880775</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson E. C.; Jamshidi F.; Johansson S. M. C.; Oberste M. S.; Arnberg N. (2008) Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential. J. Virol. 82, 3061.10.1128/JVI.02470-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02470-07</ArticleId><ArticleId IdType="pmc">PMC2259016</ArticleId><ArticleId IdType="pubmed">18184708</ArticleId></ArticleIdList></Reference><Reference><Citation>Nokhbeh M. R.; Hazra S.; Alexander D. A.; Khan A.; McAllister M.; Suuronen E. J.; Griffith M.; Dimock K. (2005) Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines. J. Virol. 79, 7087&#x2013;7094. 10.1128/JVI.79.11.7087-7094.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.11.7087-7094.2005</ArticleId><ArticleId IdType="pmc">PMC1112099</ArticleId><ArticleId IdType="pubmed">15890948</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuente J. O.; Moratorio G. (2019) Evolutionary and structural overview of human picornavirus capsid antibody evasion. Front. Cell. Infect. Microbiol. 9, 283.10.3389/fcimb.2019.00283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00283</ArticleId><ArticleId IdType="pmc">PMC6710328</ArticleId><ArticleId IdType="pubmed">31482072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zocher G.; Mistry N.; Frank M.; H&#xe4;hnlein-Schick I.; Ekstr&#xf6;m J.-O.; Arnberg N.; Stehle T. (2014) A sialic acid binding site in a human picornavirus. PLoS Pathog. 10, e100440110.1371/journal.ppat.1004401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004401</ArticleId><ArticleId IdType="pmc">PMC4199766</ArticleId><ArticleId IdType="pubmed">25329320</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J.; Hurdiss D. L.; Zocher G.; Mistry N.; Roberts R. W.; Slager J. J.; Guo H.; van Vliet A. L. W.; Wahedi M.; Benschop K.; Duizer E.; de Haan C. A. M.; de Vries E.; Casasnovas J. M.; de Groot R. J.; Arnberg N.; Stehle T.; Ranson N. A.; Thibaut H. J.; van Kuppeveld F. J. M. (2018) Role of enhanced receptor engagement in the evolution of a pandemic acute hemorrhagic conjunctivitis virus. Proc. Natl. Acad. Sci. U. S. A. 115, 397&#x2013;402. 10.1073/pnas.1713284115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1713284115</ArticleId><ArticleId IdType="pmc">PMC5777043</ArticleId><ArticleId IdType="pubmed">29284752</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko H.; Suzutani T.; Aoki K.; Kitaichi N.; Ishida S.; Ishiko H.; Ohashi T.; Okamoto S.; Nakagawa H.; Hinokuma R.; Asato Y.; Oniki S.; Hashimoto T.; Iida T.; Ohno S. (2011) Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan. Br. J. Ophthalmol. 95, 32&#x2013;36. 10.1136/bjo.2009.178772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.2009.178772</ArticleId><ArticleId IdType="pubmed">20530657</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson E. C.; Storm R. J.; Bauer J.; Johansson S. M. C.; Lookene A.; &#xc5;ngstr&#xf6;m J.; Hedenstr&#xf6;m M.; Eriksson T. L.; Fr&#xe4;ngsmyr L.; Rinaldi S.; Willison H. J.; Domell&#xf6;f F. P.; Stehle T.; Arnberg N. (2011) The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat. Med. 17, 105&#x2013;109. 10.1038/nm.2267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2267</ArticleId><ArticleId IdType="pubmed">21151139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu E.; Trauger S. A.; Pache L.; Mullen T. M.; von Seggern D. J.; Siuzdak G.; Nemerow G. R. (2004) Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J. Virol. 78, 3897&#x2013;3905. 10.1128/JVI.78.8.3897-3905.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.8.3897-3905.2004</ArticleId><ArticleId IdType="pmc">PMC374279</ArticleId><ArticleId IdType="pubmed">15047806</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnberg N.; Edlund K.; Kidd A. H.; Wadell G. (2000) Adenovirus type 37 uses sialic acid as a cellular receptor. J. Virol. 74, 42&#x2013;48. 10.1128/JVI.74.1.42-48.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.1.42-48.2000</ArticleId><ArticleId IdType="pmc">PMC111511</ArticleId><ArticleId IdType="pubmed">10590089</ArticleId></ArticleIdList></Reference><Reference><Citation>Varki A. (2008) Sialic acids in human health and disease. Trends Mol. Med. 14, 351&#x2013;360. 10.1016/j.molmed.2008.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2008.06.002</ArticleId><ArticleId IdType="pmc">PMC2553044</ArticleId><ArticleId IdType="pubmed">18606570</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst B.; Magnani J. L. (2009) From carbohydrate leads to glycomimetic drugs. Nat. Rev. Drug Discovery 8, 661&#x2013;677. 10.1038/nrd2852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd2852</ArticleId><ArticleId IdType="pmc">PMC7097102</ArticleId><ArticleId IdType="pubmed">19629075</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecioni S.; Imberty A.; Vidal S. (2015) Glycomimetics versus multivalent glycoconjugates for the design of high affinity lectin ligands. Chem. Rev. 115, 525&#x2013;561. 10.1021/cr500303t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr500303t</ArticleId><ArticleId IdType="pubmed">25495138</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundquist J. J.; Toone E. J. (2002) The cluster glycoside effect. Chem. Rev. 102, 555&#x2013;578. 10.1021/cr000418f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr000418f</ArticleId><ArticleId IdType="pubmed">11841254</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieters R. J. (2009) Maximising multivalency effects in protein-carbohydrate interactions. Org. Biomol. Chem. 7, 2013&#x2013;2025. 10.1039/b901828j.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b901828j</ArticleId><ArticleId IdType="pubmed">19421435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitov P. I.; Sadowska J. M.; Mulvey G.; Armstrong G. D.; Ling H.; Pannu N. S.; Read R. J.; Bundle D. R. (2000) Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 403, 669&#x2013;672. 10.1038/35001095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35001095</ArticleId><ArticleId IdType="pubmed">10688205</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z.; Merritt E. A.; Ahn M.; Roach C.; Hou Z.; Verlinde C. L. M. J.; Hol W. G. J.; Fan E. (2002) Solution and crystallographic studies of branched multivalent ligands that Inhibit the receptor-binding of cholera toxin. J. Am. Chem. Soc. 124, 12991&#x2013;12998. 10.1021/ja027584k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja027584k</ArticleId><ArticleId IdType="pubmed">12405825</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitov P. I.; Bundle D. R. (2003) On the nature of the multivalency effect: A thermodynamic model. J. Am. Chem. Soc. 125, 16271&#x2013;16284. 10.1021/ja038223n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja038223n</ArticleId><ArticleId IdType="pubmed">14692768</ArticleId></ArticleIdList></Reference><Reference><Citation>Spjut S.; Qian W.; Bauer J.; Storm R.; Fr&#xe4;ngsmyr L.; Stehle T.; Arnberg N.; Elofsson M. (2011) A potent trivalent sialic acid inhibitor of adenovirus type 37 infection of human corneal cells. Angew. Chem., Int. Ed. 50, 6519&#x2013;6521. 10.1002/anie.201101559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201101559</ArticleId><ArticleId IdType="pmc">PMC3210828</ArticleId><ArticleId IdType="pubmed">21648036</ArticleId></ArticleIdList></Reference><Reference><Citation>Caraballo R.; Saleeb M.; Bauer J.; Liaci A. M.; Chandra N.; Storm R. J.; Frangsmyr L.; Qian W.; Stehle T.; Arnberg N.; Elofsson M. (2015) Triazole linker-based trivalent sialic acid inhibitors of adenovirus type 37 infection of human corneal epithelial cells. Org. Biomol. Chem. 13, 9194&#x2013;9205. 10.1039/C5OB01025J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5OB01025J</ArticleId><ArticleId IdType="pubmed">26177934</ArticleId></ArticleIdList></Reference><Reference><Citation>Aplander K.; Marttila M.; Manner S.; Arnberg N.; Sterner O.; Ellervik U. (2011) Molecular wipes: application to epidemic keratoconjuctivitis. J. Med. Chem. 54, 6670&#x2013;6675. 10.1021/jm200545m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm200545m</ArticleId><ArticleId IdType="pubmed">21838327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Mu&#xf1;oz M.; Morales-Sanfrutos J.; Perez-Balderas F.; Hernandez-Mateo F.; Giron-Gonzalez M. a. D.; Sevillano-Tripero N.; Salto-Gonzalez R.; Santoyo-Gonzalez F. (2007) Click multivalent neoglycoconjugates as synthetic activators in cell adhesion and stimulation of monocyte/machrophage cell lines,. Org. Biomol. Chem. 5, 2291&#x2013;2301. 10.1039/B706331H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/B706331H</ArticleId><ArticleId IdType="pubmed">17609761</ArticleId></ArticleIdList></Reference><Reference><Citation>Liese S.; Netz R. R. (2015) Influence of length and flexibility of spacers on the binding affinity of divalent ligands,. Beilstein J. Org. Chem. 11, 804&#x2013;816. 10.3762/bjoc.11.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.3762/bjoc.11.90</ArticleId><ArticleId IdType="pmc">PMC4464470</ArticleId><ArticleId IdType="pubmed">26124882</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra A.; Sina&#xff; P. (1989) Stereoselective synthesis of 2-thioglycosides of N-acetylneuraminic acid. Carbohydr. Res. 187, 35&#x2013;42. 10.1016/0008-6215(89)80054-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0008-6215(89)80054-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornaghi L. F.; Poulsen S.-A. (2005) Microwave-accelerated Fischer glycosylation. Tetrahedron Lett. 46, 3485&#x2013;3488. 10.1016/j.tetlet.2005.03.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tetlet.2005.03.126</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer A.; Ellervik U. (2002) Study of interhalogens/silver trifluoromethanesulfonate as promoter systems for high-yielding sialylations. J. Org. Chem. 67, 7407&#x2013;7412. 10.1021/jo0262412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jo0262412</ArticleId><ArticleId IdType="pubmed">12375971</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang S. K.; Danthi P.; Chow M.; Hogle J. M. (2000) Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects. J. Mol. Biol. 296, 335&#x2013;340. 10.1006/jmbi.1999.3483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1999.3483</ArticleId><ArticleId IdType="pubmed">10669591</ArticleId></ArticleIdList></Reference><Reference><Citation>Martikainen M.; Salorinne K.; Lahtinen T.; Malola S.; Permi P.; Hakkinen H.; Marjomaki V. (2015) Hydrophobic pocket targeting probes for enteroviruses. Nanoscale 7, 17457&#x2013;17467. 10.1039/C5NR04139B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5NR04139B</ArticleId><ArticleId IdType="pubmed">26440968</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix C.; Laconi S.; Angius F.; Coluccia A.; Silvestri R.; Pompei R.; Neyts J.; Leyssen P. (2015) In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses. Virol. J. 12, 106&#x2013;106. 10.1186/s12985-015-0330-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0330-4</ArticleId><ArticleId IdType="pmc">PMC4501209</ArticleId><ArticleId IdType="pubmed">26169596</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.; Sheng J.; Fokine A.; Meng G.; Shin W.-H.; Long F.; Kuhn R. J.; Kihara D.; Rossmann M. G. (2015) Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 347, 71&#x2013;74. 10.1126/science.1261962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1261962</ArticleId><ArticleId IdType="pmc">PMC4307789</ArticleId><ArticleId IdType="pubmed">25554786</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter T. S.; Ren J.; Tuthill T. J.; Rowlands D. J.; Stuart D. I.; Fry E. E. (2012) A plate-based high-throughput assay for virus stability and vaccine formulation. J. Virol. Methods 185, 166&#x2013;170. 10.1016/j.jviromet.2012.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.06.014</ArticleId><ArticleId IdType="pmc">PMC3470038</ArticleId><ArticleId IdType="pubmed">22744000</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>